Skip to main content

Mark Adamczak

Analyst

Equibles does not estimate personal net worth.

About Mark Adamczak

Mark Adamczak has spoken on 1 earnings call across 1 company, most recently for Bionano Genomics, Inc. on August 10, 2026. The companies whose calls Mark Adamczak spoke on are classified in the Healthcare sector.

Mark Adamczak on recent calls

“Revenue for the second quarter of 2026 was $8.2 million, up 21% compared to Q2 2025, and above our guidance range of $7.5 to $7.8 million.”
2026 BIONANO SECOND QUARTER FINANCIAL RESULTS CALL ·

Company network

Recent activity